NLM Digital Collections

Search

Start Over Collections Health Policy and Services Research ✖Remove constraint Collections: Health Policy and Services Research Genre Technical Report ✖Remove constraint Genre: Technical Report

3062. Medicare: CMS should provide beneficiaries more information about substance use disorder coverage : report to Congressional committees

Publication:
Washington, DC : United States Government Accountability Office, May 2020
Subject(s):
Insurance Benefits
Insurance Coverage
Substance-Related Disorders -- therapy
Mental Health Services
Medicare
Facilities and Services Utilization
United States
Centers for Medicare & Medicaid Services (U.S.)

3065. Defense health care: efforts to ensure beneficiaries access specialty care and receive timely and effective care : report to the Committee on Armed Services, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, December 2020
Subject(s):
Health Services Accessibility
Quality Assurance, Health Care -- standards
Time to Treatment
United States
United States. Department of Defense

3066. Medicaid information technology: effective CMS oversight and states’ sharing of claims processing and information retrieval systems can reduce costs : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2020
Subject(s):
Cost Control
Information Systems -- economics
Insurance Claim Review
Medical Informatics
United States
Centers for Medicare & Medicaid Services (U.S.)

3067. Public health: federal programs provide screening and treatment for breast and cervical cancer : report to the chairman, Committee on Finance, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, October 2020
Subject(s):
Breast Neoplasms -- diagnosis
Early Detection of Cancer
Medicaid
Uterine Cervical Neoplasms -- diagnosis
United States
Centers for Disease Control and Prevention (U.S.)

3069. COVID-19: federal efforts accelerate vaccine and therapeutic development, but more transparency needed on emergency use authorizations : report to Congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, November 2020
Subject(s):
COVID-19 Vaccines
Drug Approval
Drug Development
Disclosure
United States
United States. Department of Defense
United States. Department of Health and Human Services